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Abstract
of
uslatlons served nay L.Irr•cn. A BRA VA (Blast
ct Asss r a ooduoeo
Battan banp. Adrnbodla that included mIcrobiology support. No
MASA cteo n our oatients des m courted ocrease /n
MRSA In Asia. Continued in vestiation is warranted for future
m,bsions.
Introduction
Methici II in-resistant Stuphvlococtus anren,s tMRSA) was first mc
ogniicd in 1% 1 and first reported in the Lniied States in 1968.2
Since then. the number and proportion of \IRSA isolates has been
steailv Increasing and is an issue world\\ ide. Knowledge ot the
pIe\ alence of MRS --\ in developing coumries limited. As humani
brian mssii inS continue, the epidemioloe\ of these orgamsms
becomes paramount br mission planning and pre—deplo} ment mcdi—
5Ltt/Ofl purchases.
In February. 2001. the [nited States Arm . Pacific participated in
a Blast Resuscitation and Victim Assistance i BRAVA ) mission Lit
the non—sos ernuientLil ortzanization medical facility Emergency
FOe Support for Civilian kar \ictinls in Baitambang. Cambodia.
The t1rt f ns o temis o is. ‘,unn ‘d if tst o ceneral surgeons, one
orthopedic surge in. one anesthesiologist, one operating room nurse.
one infectious disease physician. one microbiologist, and one ad
ministrator.
The composition of this team was unique and provided an oppor
tunity to pros ide assistance outside the operating theater. Knowl
edge of the hospital’s antihiogram prior to deployment did not exist
and reported clinical samples were small in ntimher. Therefore, a
portion of the mission funds was designated to enhance laboratory
capahilties md irs. prove. microbiology assets A performance im
provement project with surveillance cultures \ as therefore under
taken to determine if MRSA was present in this small hospital.
Methods
Einergenc is a non—go ernmental organization Italian facilil\
that priniaril provides surgical care for ‘s ar and blast vie trms. The
hospital operates two operating suites and three large mpatieilt
wards of approximately 60 beds bone intensive care unit and tv
pau’rit v ardsy
Iwo groups of patients had one time surveillance cultures ob
tained. Group I consisted of patients with any form of break in the
skin (open wound, fistula, pin site etc.) .A culture swab (Baxter
Culturette System, Baxter Healthcare Corp., Deerfield, IL) was
placed in contact with the open area and submitted for culture. No
skin preparation or cleaning was perlormed prior to sampling.
Within six hours, specimens were inoculated onto 5% sheep blood
agar ( Remel. Lenexa, Kansas y Bacterial cultures were incubated at
35 C for 24 hours in ambient air.
Nlnrphologicallv distinct colonies ss crc tested for coagulase and
protein A using Staphaurex I3ecton Dickinson Diagnostic Systems.
Sparks. M[) ) Staph vham n aun’us isolates were tested for growth
on \.IRSA Screen Agar Hard Diagnostic. Santa Maria. CA).
Group 2 was composed of patients without skin breaks. Anterior
nares sampline was performed in Group 2 using one culture swab
pc” patient. Identical culture techniques crc folloed with these
samples for the identification of NIRSA.
Results
Group I ssas comprised of IS patients on the inpatient ward ser ice
and Group 2 consisted of 36 patients also on the inpatient wards.
Table I shows the culture results. Four patients (28%) in Group I
and five patients (14%) in Group 2 had positive cultures br Staphy
/ocomus aureus. None of the strains were identified as MRSA.
Sensitivity testing was not possible at the local laboratory. During
the \k eek period of time that cultures were possible. there were no
post-operative wound infections or acute infections.
The four patients in Group I ss Oh S. omens wound colonization
I blast de—L’ln\ ins njnr to Ivmd.
2i open lebi helms knee amputation.
3 I open right femur wound, and
-i septic arthritis with tistula a their priniliry diagniosc.
(i ri in p 1 patient results also dem inst rated various sticpti cocci.
Psi /h/( nn.iJma md kIc1s wI/il species data in t shnss n. Sen Si
ns it\ testin was not asailiblc br these pathosens at the tinie.
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Discussion
The daportance of \IRS \ worldwide is increasing. Strains of’
NIRSA are still sensitive u anconlvcin with rare exceptions to date.
I-loss C\ er. aneomycin is onl\ ci tecOs e for NIRSA infections in the
intravenous form, As such, the cost and Ii flitations of administration
are increased over other oral antimicrobial agents. Sensitivity test
ing, when available can he used to find alternative regimens for
infections and in some cases trimethoprim/sulfametho\azole,
elindamycin. tetracycline and ervthromvcin can he used for therapy.
None of these agents howes er can he relied upon in the absence of
testmg.
As humanitarian missions increase in undersersed locations.
knowledge of antimicrobial sensitivity s ill he important for plan—
nine purpos. Prior to our arrival. specinlens for culture and
sensitis it\ were sent to a reference laboratory in Phnom Penh.
Because of the increased cost required. the number of available
results was limited. Antimicrobial agent availability was likewise
limited by cost and availahilit . During our mission preparation,
contact ss ith the hospital director revealed the lack of a database
documenting antimicrobial susceptibi lttv patterns. This Ii inited
knoss ledge created di t ficult in pre—deplo ment purchasing. It is
important to ensure that the right medications reach the hospitals and
only the medications necessary are purchased.
During the earl\ part rd he mission, we consulted the surgical
staft regarding the incidence i t staph I ococc al i nf’ect ions and the
antimicrobial susceptibilit profiles. The staff was not aware of any
MRSA issues, hut did note that penicillin w as only used on admis
sion for prophylaxis and wound infections were treated with
eeftriaxone due to its availability and relative activity against
staphylococci. We were afforded the opportunity to visit with the
r’°’ incial nnnister ot health. He reported noes idence of \IRS-\ in
thc area. hut penicillin-resistant staphylococci were the norm I ver
bal communication j.
Southeast Asia has n t been spared the ss orldwide spread ot
resistant stapll\ lococci. Rohani and others reported that 4t V ot S.
eUreus isolates from three hospitals in NIala sia were niethicilhn
resistant. From a pure geographic point of iew, data from Thailand
might provide some insight into the prevalence of MRSA in Cam
bodia. As ss ith other parts of the world, the proportion of NIRSA
isolates has also been increasing in Thailand. Between I PXS and
daS. the piopurtlon of \TRSA isolates froni the three regions rose
to about 3t’ = In contrast. only * ofstaph\ lococcal isolates ssere
resistant to \acillil ii Saigon. South y ietnanl.
(jive n thiS infornation. there is good reiisrrll to he concerned that
Cambodia is also aflected to sonic deeiee. Despite this. e ss el-C
fort u nate not to have identified an N IRS A isolates. \\ e are well
a\\ are that our surveillance was conducted with onl\ two sampling
periods and consisted ofri small number of patients. The communit\
rate of MRS.A in Battambane is unknos ii. It is not clear whether our
hunted experience has identified a nais e location or merel repre
sents sampling error. Repeat evaluatu in in the regir in is certainl
warranted.
Humanitarian missions should continue to strive for information
regarding antimicrobial susceptibility profiles among the most
common bacterial pathogens. This information is critical to miss ion
planning and may suhsequentl reduce costs 1w limiting the amount
and t\ pe of antibiotics necessar\ for a particular nn’sion. Given the
additional costs req n I ied to implement infection control policies in
NIRSA endemic areas. knowledee of their presence ould further
impact mission plannmne. We hope that this kind of surveillance will
interest other mission planners in including laboratory support and
surs eillance in futtn’e missions,
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Table 1.— Culture Results
Group 1 Group2
fl fldc)
Samples 14 36
Staphyiococcus aureus 4(28) 5(14)
MRSA 0 0
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